Clinical Trials Logo

Clinical Trial Details — Status: Terminated

Administrative data

NCT number NCT01362998
Other study ID # goodman-2
Secondary ID
Status Terminated
Phase N/A
First received
Last updated
Start date January 2011
Est. completion date June 2012

Study information

Verified date October 2022
Source Goodman, Evan, M.D.
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

For post-Cesarean analgesia, the investigators will compare the efficacy of single-shot epidural preservative free morphine with a continuous epidural fentanyl infusion. The investigators will be comparing the patient's pain level and satisfaction with the two techniques, as well as the side effects that the patients experience, such as itching, nausea, back pain and respiratory depression.


Description:

Included in the study will be all healthy (ASA I or II) woman having elective Cesarean sections who are candidates for regional anesthesia. Exclusion criteria include morbid obesity (BMI > 40), age less that 18 years, history of sleep apnea, and abuse of or intolerance to opioid analgesics. All patients will also receive 100 micrograms of fentanyl once epidurally during the Cesarean section, and they will receive ibuprofen every six hours for the first 24 hours after the Cesarean section. The patients will be visited twice a day postoperatively for two days. The epidural morphine will be expected to last only approximately 20 hours, while the fentanyl infusion will be kept in place for two days after the procedure. Additional analgesics, such as intravenous morphine or PO oxycodone and tylenol, will be available for breakthrough pain.


Recruitment information / eligibility

Status Terminated
Enrollment 2
Est. completion date June 2012
Est. primary completion date June 2011
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 50 Years
Eligibility Inclusion Criteria: - Patients having an elective Cesarean section - Healthy women (ASA I or II) - Regional anesthesia candidates Exclusion Criteria: - Morbid obesity (BMI>40) - Sleep apnea - Age under 18 - Intolerance or addiction to opioids

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Preservative free morphine
3mg given epidurally during the Cesarean section.
Fentanyl
An infusion of epidural fentanyl started during the Cesarean section. It will be given on a patient controlled analgesia basis, with a basal rate of 60 micrograms, a demand dose of 16 micrograms, and a lockout of 15 mins.

Locations

Country Name City State
United States University Hospitals Case Medical Center Cleveland Ohio

Sponsors (1)

Lead Sponsor Collaborator
Goodman, Evan, M.D.

Country where clinical trial is conducted

United States, 

References & Publications (1)

Sarvela J, Halonen P, Soikkeli A, Korttila K. A double-blinded, randomized comparison of intrathecal and epidural morphine for elective cesarean delivery. Anesth Analg. 2002 Aug;95(2):436-40, table of contents. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Other Number of Participants Who Required Additional Pain Medications Participant's nurse will be asked whether the patient required additional pain medications (Yes=1, No=0) At 8, 24, 36 and 48 hours after the Cesarean section
Primary Postsurgical Pain Participants will be asked to rate their pain on a 10 point Numerical Rating Pain Scale, where zero is no pain and ten is the most intense pain possible. At 8, 24 36 and 48 hours after the Cesarean section
Secondary Number of Participants Who Responded Yes to Having Nausea or Vomiting The patient will be asked whether she has nausea or vomiting (yes=1, no=0). At 8, 24, 36 and 48 hours after the Cesarean section
Secondary Patient Satisfaction Participants will be asked to rate their satisfaction on a 10 point Numerical Rating Scale (0=worst, 10=best). At 8, 24, 48 and 36 hours after Cesarean section
Secondary Number of Participants Who Responded Yes to Having Back Pain Participants will be asked whether they have back pain (Yes=1, No=0) At 8, 24, 36 and 48 hours after the Cesarean section
Secondary Number of Participants Who Responded Yes to Having Pruritis Participants will be asked whether they have pruritis (Yes=1, No=0) At 8, 24, 36 and 48 hours after Cesarean section
Secondary Number of Participants Who Were Observed by Their Nurse to Have Urinary Retention Participant's nurse will be asked whether >400ml was obtained by straight cath (Y=1, No=0) At 8, 24, 36 and 48 hours after Cesarean section
Secondary Number of Participants Who Were Observed by Their Nurse to Have Respiratory Depression Participant's chart will be examined to determine whether the respiratory rate was <8 per minute (Yes=1, No=0) At 8, 24, 36 and 48 hours after the Cesarean section
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05559255 - Changes in Pain, Spasticity, and Quality of Life After Use of Counterstrain Treatment in Individuals With SCI N/A
Terminated NCT04356352 - Lidocaine, Esmolol, or Placebo to Relieve IV Propofol Pain Phase 2/Phase 3
Completed NCT04748367 - Leveraging on Immersive Virtual Reality to Reduce Pain and Anxiety in Children During Immunization in Primary Care N/A
Completed NCT05057988 - Virtual Empowered Relief for Chronic Pain N/A
Completed NCT04466111 - Observational, Post Market Study in Treating Chronic Upper Extremity Limb Pain
Recruiting NCT06206252 - Can Medical Cannabis Affect Opioid Use?
Completed NCT05868122 - A Study to Evaluate a Fixed Combination of Acetaminophen/Naproxen Sodium in Acute Postoperative Pain Following Bunionectomy Phase 3
Active, not recruiting NCT05006976 - A Naturalistic Trial of Nudging Clinicians in the Norwegian Sickness Absence Clinic. The NSAC Nudge Study N/A
Completed NCT03273114 - Cognitive Functional Therapy (CFT) Compared With Core Training Exercise and Manual Therapy (CORE-MT) in Patients With Chronic Low Back Pain N/A
Enrolling by invitation NCT06087432 - Is PNF Application Effective on Temporomandibular Dysfunction N/A
Completed NCT05508594 - Efficacy and Pharmacokinetic-Pharmacodynamic Relationship of Intranasally Administered Sufentanil, Ketamine, and CT001 Phase 2/Phase 3
Recruiting NCT03646955 - Partial Breast Versus no Irradiation for Women With Early Breast Cancer N/A
Active, not recruiting NCT03472300 - Prevalence of Self-disclosed Knee Trouble and Use of Treatments Among Elderly Individuals
Completed NCT03678168 - A Comparison Between Conventional Throat Packs and Pharyngeal Placement of Tampons in Rhinology Surgeries N/A
Completed NCT03931772 - Online Automated Self-Hypnosis Program N/A
Completed NCT03286543 - Electrical Stimulation for the Treatment of Pain Following Total Knee Arthroplasty Using the SPRINT Beta System N/A
Completed NCT02913027 - Can We Improve the Comfort of Pelvic Exams? N/A
Terminated NCT02181387 - Acetaminophen Use in Labor - Does Use of Acetaminophen Reduce Neuraxial Analgesic Drug Requirement During Labor? Phase 4
Recruiting NCT06032559 - Implementation and Effectiveness of Mindfulness Oriented Recovery Enhancement as an Adjunct to Methadone Treatment Phase 3
Active, not recruiting NCT03613155 - Assessment of Anxiety in Patients Treated by SMUR Toulouse and Receiving MEOPA as Part of Their Care